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Abstract: With the ultimate goal to generate suitable materials for the repair of osteochondral 
defects, in this work we aimed at developing composite osteochondral scaffolds organized in 
different integrated layers, with features which are biomimetic for articular cartilage and 
subchondral bone and can differentially support formation of such tissues. 
A biologically inspired mineralization process was first developed to nucleate Mg-doped 
hydroxyapatite crystals on type I collagen fibers during their self assembling. The resulting mineral 
phase was non-stoichiometric and amorphous, resembling chemico-physical features of newly 
deposited, natural bone matrix. A graded material was then generated, consisting of (i) a lower 
layer of the developed biomineralized collagen, corresponding to the subchondral bone, (ii) an 
upper layer of hyaluronic acid-charged collagen, mimicking the cartilaginous region, and (iii) an 
intermediate layer of the same nature as the biomineralized collagen, but with a lower extent of 
mineral, resembling the tidemark. The layers were stacked and freeze-dried, to obtain an integrated, 
monolithic composite. Culture of the material for 2 weeks after loading with articular chondrocytes 
yielded cartilaginous tissue formation selectively in the upper layer. Conversely, ectopic 
implantation in nude mice of the material after loading with bone marrow stromal cells resulted in 
bone formation which remained confined within the lower layer.
In conclusion, we developed a composite material with cues which are biomimetic of an 
osteochondral tissue and with the capacity to differentially support cartilage and bone tissue 
generation. The results warrant test of the material as a substitute for the repair of osteochondral 
lesions in orthotopic animal models.
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With the ultimate goal to generate suitable materials for the repair of osteochondral defects, in this 
work we aimed at developing composite osteochondral scaffolds organized in different integrated 
layers, with features which are biomimetic for articular cartilage and subchondral bone and can 
differentially support formation of such tissues. A biologically inspired mineralization process was 
first developed to nucleate Mg-doped hydroxyapatite crystals on type I collagen fibers during their 
self assembling. The resulting mineral phase was non-stoichiometric and amorphous, resembling 
chemico-physical features of newly deposited, natural bone matrix. A graded material was then 
generated, consisting of (i) a lower layer of the developed biomineralized collagen, corresponding 
to the subchondral bone, (ii) an upper layer of hyaluronic acid-charged collagen, mimicking the 
cartilaginous region, and (iii) an intermediate layer of the same nature as the biomineralized 
collagen, but with a lower extent of mineral, resembling the tidemark. The layers were stacked and 
freeze-dried, to obtain an integrated, monolithic composite. Culture of the material for 2 weeks after 
loading with articular chondrocytes yielded cartilaginous tissue formation selectively in the upper 
layer. Conversely, ectopic implantation in nude mice of the material after loading with bone marrow 
stromal cells resulted in bone formation which remained confined within the lower layer. In 
conclusion, we developed a composite material with cues which are biomimetic of an osteochondral 
tissue and with the capacity to differentially support cartilage and bone tissue generation. The 





Trauma and disease of joints frequently involve structural damage to the articular cartilage surface 
and the underlying subchondral bone. These pathologies result in severe pain and disability for 
millions of  people world wide and represent a major challenge for the orthopaedic community [1-
4]. Even if a series of therapeutic approaches has been developed to treat osteochondral defects, 
none of them has proved yet to ensure long-lasting regeneration. Considering the intrinsically 
different biological, biochemical and biomechanical properties of the articular cartilage / 
subchondral bone system, several groups have directed their efforts into the generation of 
osteochondral composite materials and/or engineered tissues, using a rather large variety of 
approaches [5-10]. One of the most promising strategies consists in the generation of heterogenous 
scaffolds, obtained by the combination of distinct but integrated layers corresponding to the 
cartilage and bone regions. Such design is based on the recognition of the different requirements to 
regenerate the cartilage and bone parts of an osteochondral defect, and at the same time prevents the 
risk of delamination of different components, if these are adjacent but physically separated. 
The generation of integrated, bilayered osteochondral scaffolds has been initially proposed using α-
hydroxy acids polymers (i.e., poly-lactic acid, poly-lactic-coglycolic acid), combined with a 
ceramic component (i.e., hydroxyapatite, tricalcium phosphate) in the region corresponding to the 
subchondral bone [11-12] More recently, biphasic but monolithic materials were formed by joint 
freeze drying and chemical crosslinking of collagen-based materials (i.e., mineralised or coupled 
with hyaluronic acid), as well as by ionotropic gelation of alginate-based materials (i.e., containing 
or not hydroxyapatite ceramic particles), allowing to achieve specific mechanical properties (i.e., 
elasticity or compression strength) [13]. 
Along the direction of designing biomimetic osteochondral composite scaffolds resembling the 
composition of the extracellular matrices of cartilage and bone tissue, in this study we first aimed at 
further developing a previously reported process of nucleation of hydroxyapatite nanocrystals onto 
self-assembled collagen fibers [14]. We then generated chemically and morphologically graded 
hybrid materials, built by stacking a lower mineralised layer produced according to the newly 
developed technique, an intermediate layer with reduced amount of mineral to mimic the tidemark 
and an upper layer formed by collagen and hyaluronic acid, reproducing some cartilaginous 
environmental cues. Finally, we addressed whether the resulting composite materials would 
differentially support cartilage and bone tissue formation in the different layers, when loaded with 
articular chondrocytes or bone marrow stromal cells.
* Manuscript
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2. Materials and Methods
2.1. Material processing and composite development
The organic component, working as matrix mediating the mineralization process, was type I 
collagen (Coll) extracted from equine tendon, telopeptides free and supplied as acetic gel (an 
aqueous acetic buffer solution with pH=3.5 containing 1wt% of pure collagen). Type I collagen was 
selected for the synthesis of the composite layers, including the cartilaginous one, due to (i) its good 
physico-chemical stability and processability and (ii) high safety and biocompatibility profile, 
related to the removal of all telopeptides, which are potentially responsible for immunological 
reactions. The mineral phase, represented by hydroxyapatite (HA) and/or magnesium-
hydroxyapatite (MgHA) was directly nucleated onto collagen fibers during their self assembling. 
Magnesium ions were introduced to increase the physico-chemical, structural and morphological 
affinity of the composite with newly formed natural bone [15]. In order to generate a scaffold with a 
morphological and mineralization gradient, three different layers were prepared: a) the upper one, 
mimicking the cartilagineous layer, and composed of Collagen and Hyaluronic acid; b) the 
intermediate one, mimicking the tide-mark,  and composed of HA/Coll (40/60 wt%) composite; c) 
the lower one, mimicking the subchondral bone, and composed of HA/Coll (70/30 wt%) composite.
Synthesis of the cartilagineous upper layer: 100 g of 1wt% type I collagen in acid suspension were 
precipitated by  the addition of NaOH (0.1M) solution up to pH 5.5. The precipitate was then 
washed three times with 300 ml of water. Finally 0.1wt% of hyaluronic acid (HYA: 
P.M.=1.700.000 uma) was added to the gel just before the crosslinking treatment.
Synthesis of the intermediate bony layer (tidemark): 100 ml of H3PO4 (0.040M) solution, mixed 
with 100 g of 1wt% collagen gel, were dropped in a basic suspension, containing 0.491 g of 
Ca(OH)2 in 750 ml distilled water to yield a composite HA/Col material in the ratio 40/60wt%.
Synthesis of the lower bony layer: 244 ml of H3PO4 (0.040M) solution, added with 70 g of 1wt% 
collagen gel, was dropped in a basic suspension containing 1.203 g of Ca(OH)2 in 184 ml of 
distilled water to yield a composite HA/Col material in the ratio 70/30 wt%. The same 
mineralization process was also performed to nucleate Mg doped HA on collagen fibers. In 
particular, 244 ml of H3PO4 (0.040M) solution, mixed with 70 g of 1wt% collagen gel, were 
dropped in a basic suspension containing 1.203 g of Ca(OH)2 and  MgCl2  in 184 ml of distilled 
water. The amount of MgCl2 was calculated to obtain a molar ratio XMg (Mg/Ca) = 5% in the 
mineral phase. The drop wise addition procedure was performed  under stirring and assuring a slow 
decrease of pH [14]  up to neutrality ( total dropping  time for the considered volumes 30 min.).
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Each  synthesized material was treated with the crosslinking agent 1,4-butanediol diglycidyl ether 
(BDDGE) through immersion for 48 hours in a BDDGE aqueous solution (2.5 mM), setting up a 
BDDGE/collagen ratio equal to 1wt%. After this cross-linking treatment, each preparation was 
filtered and layered on Mylar sheet. The thicknesses of the cartilaginous, intermediate and bony
layers (respectively about 2.0, 1.5 and 2.5 mm) were selected on the basis of technological 
limitations (preparations thinner than 1.5 mm are challenging) and of the dimension of native
articular cartilage in the sheep joint (selected as in vivo test model). The three layers were piled up, 
then a knitting procedure [16] was applied at each interface (bone-tidemark interface and tidemark-
cartilage interface) to assure good integration by the exchange of anchor fibers between the layers 
and avoid delamination at the interface. Finally, freeze-drying with a controlled freezing and 
heating ramp was performed from 25°C to -25°C and from -25°C to 25°C in 50 min., under vacuum 
conditions (P = 0.20 mbar) .
2.2 Composite characterization
ICP-OES quantitative analysis, using an inductively coupled plasma - atomic emission 
spectrometry (ICP-AES: Liberty 200, Varian, Clayton South - Australia), was applied to determine 
the content of Mg2+, Ca2+, PO4
3- ions constituting the mineral phase forming the composites. 
Samples were previously prepared using an acid attack (nitric acid 65wt%). The obtained values 
were expressed in term of Ca/P and Mg/Ca molar ratios. The composites were examined by 
scanning electron microscopy (ESEM) (Quanta 600 FEG, FEI Company, Hillsboro, OR) equipped  
with EDS (analyzing program: EDAX Genesis, Mahwah, NJ). Infrared spectroscopy (FTIR) was 
performed by  using a Nicolet 4700 Spectroscopy on  pellets (13 mm ) which  were prepared by 
mixing 2 mg of ground sample with 100 mg of KBr in a mortar and pressing. Collected X-ray 
diffraction patterns were recorded by a Bruker AXS D8 Advance instrument in reflection mode 
with Cu-Ka radiation and by a Rigaku Miniflex diffractometer (Cu-Ka radiation). The samples were 
ground through a cryo-milling apparatus to obtain relatively uniform particle size powder.
Observations of composites materials by transmission electron microscopy (TEM) were performed 
with a JEOL EX4000 instrument with acceleration potential of 400 kV. Samples were dispersed on 
lacy carbon Cu grids by contact with the grids and subsequent gentle shaking.
Enzymatic tests were performed on mineralized and non-mineralized materials using 200 U/ml of 
Collagenase solution (in 0,1 M Tris-HCl pH=7.4). The kinetics of enzymatic degradation was 
followed by an UV-visible spectrophotometer, that allowed to observe the different absorbance in 
function of time. At  λ = 280 nm the absorption of the aromatic amino-acids tyrosine and tryptophan 
occurs and it is possible to estimate the increase of concentration of degraded collagen in solution.
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Solid state 13C NMR spectra were performed at 50.33 MHz on a Bruker AC-200, equipped with an 
HP amplifier. Samples were finely powdered and packed into 4 mm zirconia rotors and sealed with 
Kel-F caps.
Mechanical tests were performed on mineralized specimens (bars 3mm x 7mm x 60mm) obtained 
through cold uni-axial pressing at different pressures of freeze dried HA/Coll 70/30 composite 
materials and having different final porosities. Three specimens have been prepared for each pre-
selected porosity (in the range 45-65 vol%). Young’s Modulus was measured by resonant frequency 
method using an H&P gain phase analyzer (Yokogama, Hewlett Packard, Tokyo, Japan) and 
flexural strength σ through the 4-point (lower span = 40mm, upper span = 20 mm) bending method 
(Instron machine model 1195, High Wycombe, Bucks, UK) using a crosshead speed of 1mm/min.
The σ value has been calculated applying the formula σ =3PN * a/bd2 where PN is the load in N and b 
and d are respectively the width and  the height of the specimen and a is the outer span.
2.3 Cell isolation and expansion
For the biological validation of the developed composites, we used different cell systems which 
have been previously shown to efficiently differentiate towards the chondrogenic and osteogenic 
lineages, i.e. respectively human expanded chondrocytes [17] and sheep bone marrow stromal cells 
(BMSC) [18]. 
Full-thickness human articular cartilage biopsies were obtained post mortem (within 24 h after 
death) from the lateral condyle of knee joints of 2 individuals with no history of joint disease, after 
informed consent by relatives and in accordance with the local ethics committee of University 
Hospital Basel, Switzerland. Cartilage tissue was minced, digested with 0.15% type II collagenase 
(10 mL solution/g tissue, 300 U/mg, Worthington Biochemical Corporation, Lakewood, NJ) for 22 
hours and the isolated chondrocytes resuspended in Dulbecco's modified Eagle's medium containing 
10% fetal bovine serum, 4.5 mg/mL D-glucose, 0.1 mM nonessential amino acids, 1 mM sodium 
pyruvate, 100 mM HEPES buffer, 100 U/mL penicillin, 100 µg/mL streptomycin, and 0.29 mg/ml 
L-glutamine (complete medium). Chondrocytes were expanded in complete medium with the 
addition of 1 ng/ml of transforming growth factor-b1, 5 ng/ml of fibroblast growth factor-2 and 10 
ng/ml of platelet-derived growth factor-bb in a humidified 37°C/5% CO2 incubator, as previously 
described [17]. BMSC were obtained from sheep iliac crest marrow aspirates of 3 year old ewes. 
All procedures were approved by the Institutional Ethical Committee. BMSC were cultured as 
described [18]. Mononuclear cells were plated at 5x106 in 100mm dishes in Coons modified Ham’s 
F-12 medium supplemented with 10% FCS and 1ng/ml human recombinant FGF-2 (Austral 
Biologicals, San Ramon, CA). Medium was changed after 3 days and twice weekly. 
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2.4 Generation and culture of chondrocyte-scaffold constructs
Expanded human articular chondrocytes were resuspended at a concentration of 2x108 cells/mL and 
aliquots of 80µl (i.e., 1.6x107 cells) were statically loaded onto the composite scaffolds (8mm 
diameter, 6 mm height disks), either from the cartilaginous or from the subchondral bone layer.
Chondrocyte seeded scaffolds were then transferred to agarose-coated dishes and cultured for two 
weeks in complete medium supplemented with 0.1mM ascorbic acid 2-phosphate, 10µg/mL insulin 
and 10ng/mL TGFβ3 (chondrogenic medium), with medium changes twice a week.
2.5 Generation and implantation of BMSC-scaffold constructs
Expanded sheep BMSC were resuspended at a concentration of 2.0x107 cells/mL and aliquots of 
100µl (i.e., 2.0x106 cells) were statically loaded onto the composite scaffolds (8mm diameter, 6 mm 
height disks), both from the cartilaginous and from the subchondral bone layer. BMSC/scaffold 
composites,  in agreement and with the approval of the competent ethical committee and legal 
authorities, were subcutaneously implanted in immuno-deficient (ID) (CD-1 nu/nu) mice by using 
an established model of ectopic bone formation [18]. Recipient ID mice of 1 month of age, 
purchased from Charles River Italia, were kept in a controlled environment and given free access to 
food and water. Mice were anesthetized by intramuscular injection of Xilazine (20 g/ml) and 
Ketamine (30 g/ml). Bioceramic/BMSC composites were implanted subcutaneously on the back 
of the mice. A total of 3 constructs were implanted in 3 different mice. Animals were sacrificed 8
weeks after implantation. Grafts were harvested and processed for histological analysis.
2.6 Histological characterization of generated constructs
Immediately after cell seeding or following 2 weeks culture, chondrocyte-scaffold constructs were 
fixed in 4% formalin, embedded in paraffin, cross-sectioned and stained with Safranin-O for 
sulfated glycosaminoglycans (GAG). BMSC-scaffold constructs were formalin fixed after 
explantation following 8 weeks in ID mice, embedded in paraffin, cross-sectioned and stained with 
hematoxylin-eosin.
3. Results and Discussion
3.1 Development and characterization of the lower (bony) and intermediate (tidemark) layers
The  selected procedure, differently from  processes previously reported, implies the dispersion of 
collagen into the acid solution and the addition drop-wise  of this mixture into the basic dispersion 
- 6-
so that to maintain  basic condition (pH>8) for almost all the process. Under these conditions, the 
fibril formation takes place before the precipitation of calcium phosphate, which is crucial since the 
collagen fibrils are supposed to act as templates for the mineralization. Upon decrease of pH lower 
than 8, amorphous HA forms onto the fibrils before their assembling into fibers. Approaching 
neutral pH  two processes enter  in competition, involving the same  binding  chemical groups on 
the surface of the fibers: the organization of collagen fibers into a three-dimensional network  and 
the  proceeding  HA crystallization  [13,14,19,20] . 
The final porosity of the spongy mineralized composites was directly dependent on the freezing 
temperature, heating ramp and the content of water into the starting gel. When the freezing 
temperature was settled at -25°C, with a heating ramp set at 1°C/min the large pores appeared 
anisotropic, with the largest dimension in the range 250-450 m (Fig. 1). Lowering of the freezing 
temperature up to -40°C induced a decrease of the pore diameters and an eccessive pore anisotropy 
[13]. By knitting the collagen/HA gel we assured the formation of  macropores up to 400m [21]. 
Among the several methods used to define the micro-macro porosity and the interconnectivity of 
the mineralized  composites, XRay CT  was also employed with a local resolution of 10 m,  
revealing a total porosity around 80%, a surface-to-volume ratio of  0.116  and a pore wall thickness 
of about 15 -20 m. 
Results of  the ICP analysis  of the HA/Coll composites are reported  in Table 1: the different values 
of the Ca/P ratio of HA and  Mg doped HA, nucleated on Collagen, are in the range of low 
crystallinity HA ( 1.45-1.60): in fact the presence of HPO42- in low crystallinity apatites 
contributes to lower the ratio. In the case of composites Mg-HA/Coll 70/30 wt%, the amount of Mg 
substituting Ca is exactly as expected, i.e. about 50% of the starting nominal concentration of Mg 
[22, 23]. On the contrary, when the inorganic/organic ratio is lowered at 40/60 HA/Coll the amount 
of Mg substituting Ca into HA structure  decreased. The XRD analysis of HA/Coll composite 
displayed a pattern typical of very low crystallinity HA; the estimated crystallite size along c axis 
was around 12-15 nm. The nucleation occurred according to the process typical of natural bone, 
where the nano-size dimension of crystallites is responsible of the large broadening of reflections in 
the pattern. Such nanocrystals were growing inside collagen fibers with their c axes preferentially 
oriented parallel to the direction of orientation of the fibers [14, 24, 25]. In the case of the 
composite containing Mg-HA, the XRD pattern (Fig. 2) had a profile typical of amorphous phase. 
In the case of composites with lower inorganic/organic phase ratio (40/60) it was systematically 
observed that the diffraction peaks (see Fig. 2b) began to be resolved: actually in the composite 
with lower HA/Coll ratio, the amount of magnesium entered into the HA lattice was lower and thus 
the crystallinity of HA phase increased [22]. A possible explanation could be linked to the higher 
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affinity of Ca2+, with respect to Mg2+, to link COO- groups of collagen, therefore when the HA/Col 
ratio is  40/60 most of the mineral phase grows in tight contact with collagen fibers and Ca2+ ion 
(instead of Mg2+) preferentially binds carboxylic groups present at the surface of collagen fiber, 
therefore maintaining its place within the HA lattice. Differently behaves the HA phase not directly 
contacting the organic fibers, where the competition between magnesium and calcium is mainly 
controlled by the nucleation and subsequent crystallization kinetics. The complete absence of any 
undesirable crystalline secondary phase in all the preparations, even after a thermal treatment up to 
800°C, is a further important information that can be drawn out by XRD analysis.  
The mineral phase was evaluated from a typical set of HREM images (Fig. 3). The HA crystals 
nucleated on the organic fiber exhibited a rod like structure (Fig. 3a). When Mg2+ substituted Ca2+, 
the nuclei of mineral phase had a globular shape and smaller dimensions (Fig. 3b). The inset of Fig. 
3b displays at higher magnification the Mg-HA nucleus on collagen fiber. The analysis of the high 
resolution images and its Fourier Transform (FT) (inset c in Fig. 3b) revealed that this shape is 
accompanied by a lack of order and the particles appear completely amorphous, as indicated by the 
intense diffuse ring and by the complete lack of spots in the FT of the image. It must be stressed 
that the degree of disorder observed for this sample does not correspond to a short range order (as 
the case of low crystalline inorganic HA) but to a “true amorphous” structure [25]. These data 
indicate that, despite comparable synthesis conditions were used, the structural features of the 
mineral phase in the composite are completely different from that nucleated in the absence of an 
organic template [26], moreover, during mineralization, a structural control was accomplished  
through  the preferential nucleation of a specific crystal face/axis, by molecular recognition, at the 
surface of the organic template. Since  Mg  has different polarity, structure and stereochemistry (as 
compared to Ca) the activation energy controlling the nucleation rate changes and this reflects in a 
modification of site-specificity, mineral structure and crystallographic alignment [19, 27]. Another 
clear  evidence of the chemical interaction between HA and collagen fibers comes from the study of 
the FTIR spectra (Fig. 4a), in which a shift from 1340 to 1337 cm-1 of the band corresponding to the 
stretching of –COO- group of collagen, was observed. The band at 870 cm-1 was stronger for 
HA/Coll composites, indicating that the nucleation of HA into collagen implies carbonation of the 
inorganic phase. Moreover the carbonation can be assigned only to the B position as confirmed by 
the absence of the band at 880 cm-1 and by EDS analysis (after collagen elimination by enzymatic 
digestion), which revealed that the increase of the C content (in the CO3
2- groups) corresponds to a 
decrease in P concentration. Similarly, Mg-HA nucleated on collagen results spontaneously 
carbonated and therefore the actual theoretical formula of the mineral phase becomes:
[(Ca, Mg)10-x/2(PO4)6-x(CO3)x(OH)2].
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Thus, like in the natural mineralization process, it was  possible to recognize also a chemical control 
mechanism which occurred during the nucleation and crystals growth and was mainly achieved by 
the regulation of ion movement and the kinetic competition between the fibrils assembling and HA 
nucleus formation [19]. In Fig. 4b a comparison between  HA/Coll and  Mg-HA/Coll  is reported: 
normally, the low site symmetry of the PO4
3- tetrahedron of crystalline HA splits the 4 PO43-
contour into three components which fall near 630, 600, and 550 cm-1. It is possible to observe that 
the triplet tends to merge in two and one broad band in HA/Coll composite and Mg-HA/Coll 
composite respectively. In addition, the broad band centered between 550 and 560 cm-1, assigned to 
acid phosphate (HPO4
2-) in the mineral lattice, was much more intense in Mg doped HA nucleated 
on Collagen. These peculiarities of MgHA/Coll can be similarly observed in the FTIR spectrum of 
young bone; while they tend to disappear in mature bone and in highly crystalline synthetic apatite 
[28-30]. Correlation was noted between the fractional intensity of ~1050 cm-1 band  related to PO4
3-
group and the crystal size of the apatite: a reduction of the apatitic crystal size induced an increase 
of the percentage area of this component [31, 32]. All these features indicate that the mineral phase 
containing Mg ions and nucleated on the natural template (collagen) is non-stoichiometric and 
remarkably amorphous resembling very well the features of newly deposited bone mineral.
Flexural strength (σ) was determined on the HA/Coll 70/30 wt% dry composites revealing a 
pseudo-plastic behavior. Due to technological obstacles some samples turned out extremely non-
homogeneous and this is reflected in very different behavior under loading.  The flexural strength 
decreased from about 20 to 5 MPa as the specimen porosity increased from about  45 to 63 vol% 
(Table 2).   From the regression curve of the strength and porosity data,  the equation:                 
     y = 330.5 e-6.8481x
was derived and σ value at zero porosity was also calculated ( = 330 MPa), that can be considered 
an approximation of the strength of the  material at full density). Elastic modulus (Young’s modulus 
- E) determined on the mineralized layer well reproduced the value found for trabecular bone at 
correspondent values of porosity (Table 2).
3.2 Development and characterization of the upper cartilagineous layer
The pure collagenic portion (mimicking cartilage) was added with hyaluronic acid to create bridges 
between the collagen fibers and, through the introduction of this saccharidic structure rich in polar 
hydrogen atoms, to  modify the hydrophilicity of the system. In Fig. 5 the ESEM image shows the 
details of the hyaluronic acid bridges. The porosity of the cartilagineous layer is visible in the inset 
of Fig. 5 and was evaluated by image analysis: the pores result more isotropic if compared with the 
mineralized composite and the average pore diameter was in the range of 100-150 m. Solid state 
- 9-
NMR analysis was performed on the collagenic (cartilaginous) layer with and without hyaluronic 
acid to confirm its presence (Fig. 6), while detailed quantitative analysis are in progress.
BDDGE (1,4-butanediol diglycidyl ether) was added to the three different layers as cross linking 
agent to stabilize collagen and retard its degradation  kinetic. However the effect of the cross-
linking agent on the material morphology is more evident on collagen when the mineral phase is 
absent. A comparison  between the morphology of the freeze dried collagen and freeze dried 
collagen + BDDGE is shown is Fig. 7, highlighting the different morphology induced by BDDGE 
and the higher number of links between the collagen bundles in the cross-linked sample. Enzymatic 
tests carried out on the different layers using Collagenase revealed that the mineral phase retards the 
degradation of collagen and BDDGE further stabilizes the HA/Coll composite: HA/Coll 70/30 wt%
degraded completely in 38hrs, while HA/Coll 70/30 wt% + BDDGE in 78hrs. On the other hand, 
Collagen/Hyaluronic Acid degraded in 3.5hrs while Collagen/Hyaluronic Acid + BDDGE in 7hrs. 
A more detailed description of tests and the nature of link formed between collagen and BDDGE in 
function of pH will be discussed in a  following paper.
3.3 Development and test of the three-layered scaffold
The rationale to fabricate a three-layered scaffold instead of a bi-layered one is based on  the 
consideration that gradual changes in the mechanical features of the layers, due to different
stiffnesses of the differently mineralized fibers, could reduce the mismatch of properties at the 
interface and increase the composite stability.  Fig. 8 displays the ESEM image of the graded 
composite: it is possible to distinguish a disordered lower layer that corresponds to the mineralized 
one, a second layer, with lower mineralization extent, which corresponds to the tidemark and a third 
layer in which the propagation of a planar ice front [33] during a freeze-dry cycle, causes the 
formation of a columnar-like structure converging towards the external surface where it forms 
horizontal flat ribbons, resembling the morphology of the lamina splendens. In the lower layer, the 
higher density and scarce flexibility of  the mineralized fibers  hamper the formation of a 
directionally ordered  structure during freeze-drying. Pulling tests on dry and wet samples were 
manually performed and the detaching interfaces evaluated: in a statistically significant number of 
tests the separation occurred in a random position (not at the layers interface), proving that the 
knitting procedure assures a good adhesion between the mineralized layers and the cartilagineous 
one.
Chondrocytes statically loaded in the composite scaffolds remained mostly confined within the 
seeded layer and their distribution within the layer was rather non-uniform (Fig. 9 a, b). Cells 
appeared more sparse and at lower density in the subchondral bone than in the cartilaginous layer. 
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After 2 weeks in chondrogenic medium, cells in the cartilaginous layer displayed a chondrocytic 
morphology and generated a cartilaginous tissue positively stained for Safranin O (Fig. 9c), while 
cells in the subchondral bone layer remained fibroblastic and did not accumulate histologically 
detectable amounts of glycosaminoglycans (Fig. 9d). The scaffold regions initially void of cells, 
especially those in the central core, remained essentially acellular (data not shown). After 8 weeks 
in ID mice, BMSC loaded in the composite scaffold generated a nicely structured bone tissue 
confined in the bone layer and a loose connective tissue in the cartilagineous layer (Fig. 10).
The obtained results demonstrate that the cartilaginous layer of the composite scaffold is permissive 
to human articular chondrocyte differentiation and cartilaginous matrix deposition, whereas only a 
fibrous tissue could develop in the subchondral bone layer. Conversely, bone tissue formation was 
supported within the subchondral layer of the composite, but not in the cartilaginous region. Further 
studies are required to establish whether the differential tissue formation is due to the initially 
different density of seeded cells, to the different architecture of the layers (e.g., pore size) or to 
effectively biomimetic cues in their composition (e.g., hydroxyapatite, hyaluronic acid component). 
The role of 3-layered composites, as compared to 2-layered structures, will also have to be 
addressed in orthotopic animal models.
4. Conclusions
HA/Coll bio-hybrid composites were prepared through a biologically inspired mineralization 
process. The presence of magnesium, doping hydroxyapatite nucleating on collagen (Mg-HA/Coll),  
induces in the composite those physico-chemical, structural and morphological  features typical of 
newly formed natural bone. Actually, during the artificial mineralization process, intrinsic control 
mechanisms such as regulation of chemistry, morphology and spatial distribution of the mineral 
phase occur, similarly to what happens in natural biomineralization process. Compositionally and 
morphologically graded scaffolds, made with the bio-hybrid composites, displayed the ability to 
support selective cell differentiation towards the osteogenic and chondrogenic lineages. Further 
studies are ongoing to test whether the biomimetic properties of the graded scaffold can induce 
orderly repair of osteochondral defects in a large size animal model.
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Figure captions 
Figure 1: SEM image of the mineralized  bony layer  made of 70/30 wt% HA/Coll
Figure 2: X ray diffractogram of MgHA/Coll (70/30)wt (a), MgHA/Coll (40/60)wt  (b)
Figure 3: Set of HREM images: TEM micrography of freeze milling HA/Coll (70/30)wt composite (a) and  TEM 
micrography of freeze milling MgHA/Col (70/30)wt composite (b). Insert (c): high resolution HREM images and Fourier 
Transform.
Figure 4 : FTIR analyses of apatite/Collagen composites containing different mineral phases (HA, MgHA) compared with 
crystalline HA (a) and detail of PO4 peak area comparison (b).
Figure 5: ESEM micrography of the morphology of the  cartilaginous layer  made of collagen containing Hyaluronic acid 
Figure 6: Solid State NMR analysis : freeze dried collagen (a) and freeze dried collagen with Hyaluronic Acid added (b).
Figure 7:  ESEM micrography of freeze-dried natural collagen (a) and BDDGE cross-linked collagen (b).
Figure 8 ESEM micrography of osteochondral scaffold morphology: three different layers are distinguishable due to the 
different content of mineral phase, that increases moving from the upper (cartilagineous: collagenic only) to the 
intermediate (tide-mark: HA/Coll 40/60wt composite), to the lower layer (bone layer: HA/Coll 70/30wt composite). The 
inset shows the detail of the morphology of cartilaginous (upper) layer: a columnar-like structure converges towards the 
external surface where it forms horizontal flat ribbons, resembling the morphology of the lamina splendens.
Figure 9 Representative safranin O-stained cross-sections of constructs after seeding (a,b), or following two weeks of 
culture in chondrogenic medium (c,d) of scaffolds seeded from the cartilaginous layer (a,c) or from the subchondral bone 
layer (b,d). Scale bar = 100  µm (or 50 µm for the inset in c)
Figure 10: Histological characterization of BMSC generated constructs. The histological analysis of BMSC loaded 
constructs retrieved after 8 weeks of  in vivo implantation in ID mice revealed a nicely formed bone tissue limited to the 
construct bone layer (upper part of the panel) and a loose connective tissue in the construct cartilagineous layer (lower 
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Table 1: ICP-OES quantitative analyses of apatite/collagen composites.
Ca2+ (mol) Mg2+ (mol) PO4






HA / Coll 
(70/30)wt
1.870 --- 1.144 1.635 --- ---
MgHA / Coll 
(70/30)wt
1.315 0.035 0.857 1.534 1.575 2.662
MgHA / Coll 
(40/60) wt
1.419 0.027 0.983 1.444 1.471 1.903
Table
Table 2: Flexural strength (σ) values (three point bending method for flexural strength evaluation)
and Young’s modulus (E) values obtained for HA/Coll 70/30 bars having different porosity value 





Young’s modulus E 
(GPa)
45.3 17.56 6.85
45.9 23.23 4.51
46.7 7.46 6.29
51.5 7.86 3.44
52.4 8.77 2.00
54.1 9.05 3.91
62.0 4.68 1.81
62.6 4.92 1.65
63.3 6.11 1.50
Table
